HugoScore hugoscore.org

Full review

Apple Health+ / Apple health coach (Project Mulberry) CAIHL draft report

Evidence-linked HugoScore draft report for a health AI tool that affects patients.

Back to profile Markdown source

HugoScore CAIHL Draft Report: Apple Health+ / Apple health coach (Project Mulberry)

Status: Draft for human review. Watch list, pre-launch. Nothing in this report is verified against a shipped product. Last reviewed: 2026-06-12 Review method: Public-source review of credible pre-launch reporting (Bloomberg via 9to5Mac, MacRumors, TechCrunch), updated with WWDC 2026 coverage. Apple has published no official product page, no product exists to test, and nothing in this entry is verified against a shipped product. Service: Apple Health+ / Apple health coach (Project Mulberry) Vendor: Apple Category: Wearable AI coach

Summary

Apple's AI health coach has not launched as of June 12, 2026. Everything known about it comes from press reporting, mostly sourced to Bloomberg's Mark Gurman, under the codename Project Mulberry and the unofficial name Apple Health+, sometimes called Apple Coach. Reporting since March 2025 has described an AI agent that gives personalized health guidance from Apple Health and Apple Watch data, a redesigned Health app, educational videos from real doctors, food tracking, and camera-based workout form feedback, possibly behind a subscription. The timeline has slipped repeatedly. The feature was reported for iOS 26.4 in spring 2026, then scaled back in February 2026 after reports that Apple judged it not yet competitive, then reported in May 2026 as further delayed, with features expected, if at all, later in the iOS 27 cycle after Eddy Cue took over Apple's health group. WWDC 2026 introduced iOS 27 and watchOS 27 features, including Siri AI updates and incremental Health app additions, but no AI health coach, Health+ service, or redesigned Health app was announced. Some Mulberry features may arrive piecemeal inside the Health app rather than as a standalone service.

From a CAIHL perspective, no judgment is possible or responsible yet. There is no product, no privacy documentation, no boundary language, no pricing, and no evaluation evidence. The entry exists because Apple's installed base means any launch would instantly affect a very large patient population, and because the reported design choices worth watching are already visible: a coach that partly replicates a doctor, possible subscription gating of health guidance, and reported FDA-related caution inside Apple. This profile is a placeholder that states what credible reporting says and nothing more. It must be rewritten from official sources at launch.

Evidence Reviewed

CAIHL Profile

  • Who does this AI serve? Not assessable. Reporting describes a patient-facing coach over the user's own device data, inside Apple's hardware and subscription ecosystem. Who it actually serves depends on launch decisions not yet made public.
  • Can patients tell AI is involved? Not assessable. The reported design is an explicit AI coach, which would be visible by definition, but no interface exists to verify.
  • Can patients meaningfully choose? Not assessable. Opt-in mechanics, refusal options, device requirements, and the reported Health+ subscription are all unconfirmed.
  • Can patients correct or challenge what the AI produces? Not assessable. No correction or deletion mechanisms exist to review.
  • Does it help patients understand or act? Not assessable. Reported features point at action support, but reported features are claims about an unshipped product.

Agency Interpretation

If the reported design ships, the agency potential is significant. Apple devices already hold continuous health data for hundreds of millions of people, and Apple's privacy posture on existing Health data is comparatively strong. A coach that interprets that data for the person who generated it could expand understanding at population scale.

The watch-list tensions are equally clear. A coach that partly replicates a doctor raises boundary and escalation questions that Apple has not publicly addressed. A subscription tier would gate health understanding behind payment inside an already premium ecosystem. And repeated delays attributed to quality and regulatory caution are themselves informative: they suggest Apple does not yet believe the product meets its own bar. None of these are findings. They are the questions this entry exists to hold open until launch.

Key Unknowns

  • Whether the product will ship at all, in what form, and when in the iOS 27 cycle.
  • Whether it launches as a standalone Health+ subscription, a bundled service, or piecemeal Health app features.
  • All data governance facts: collection, retention, training use, on-device versus cloud processing, sharing, deletion.
  • Clinical boundary language, escalation behavior, and any FDA interaction.
  • Pricing, device requirements, regional availability, and accessibility.
  • Who evaluates it, against what standard, and whether patients have any role.

Publication Recommendation

Ready for human review as a watch-list entry only. It should be published, if at all, clearly flagged as pre-launch with nothing verified. Re-research immediately when Apple announces or ships the product, and replace every reported claim with official documentation at that point.